S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:VBIVVBI Vaccines Earnings Date, Estimates & History

$3.50
-0.15 (-4.11 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.31
Now: $3.50
$3.84
50-Day Range
$2.57
MA: $4.04
$6.17
52-Week Range
$0.47
Now: $3.50
$6.93
Volume7.61 million shs
Average Volume9.60 million shs
Market Capitalization$809.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.85

Earnings

VBI Vaccines (NASDAQ:VBIV) Earnings Information

VBI Vaccines last announced its earnings data on July 31st, 2020. The biopharmaceutical company reported ($0.04) EPS for the quarter, meeting the consensus estimate of ($0.04). The firm had revenue of $0.18 million for the quarter, compared to analysts' expectations of $0.86 million. VBI Vaccines has generated ($0.46) earnings per share over the last year. VBI Vaccines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2020 based off prior year's report dates.

VBI Vaccines Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VBI Vaccines (NASDAQ:VBIV) Earnings Estimates

2020 EPS Consensus Estimate: ($0.14)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.06)($0.06)($0.06)
Q2 20201($0.08)($0.08)($0.08)
Q3 20201($0.08)($0.08)($0.08)
Q4 20201$0.08$0.08$0.08

VBI Vaccines (NASDAQ VBIV) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/4/2020
(Estimated)
       
7/31/20206/30/2020($0.04)($0.04)($0.04)$0.86 million$0.18 millionN/A
5/6/20203/31/2020($0.06)($0.05)($0.05)$0.83 million$0.42 millionN/A
3/5/202012/31/2019($0.06)($0.02)($0.02)$0.97 million$0.57 millionN/A
11/6/2019Q3($0.1270)($0.15)($0.15)$0.90 million$0.65 millionN/A
8/9/20196/30/2019($0.15)($0.13)($0.13)$0.60 million$0.64 millionN/A
5/1/2019Q1($0.1530)($0.15)($0.15)$0.20 million$0.36 millionN/A
2/25/2019Q4 2018($0.19)($0.28)($0.28)$2.13 million$2.68 millionN/A
11/9/20189/30/2018($0.22)($0.24)($0.24)$0.24 million$0.26 millionN/A
7/26/20186/30/2018($0.17)($0.26)($0.26)$0.23 millionN/A
5/1/20183/31/2018($0.16)($0.19)($0.19)$0.21 million$0.18 millionN/A
11/13/2017Q3 2017($0.23)($0.24)($0.24)$0.15 million$0.19 millionN/A
7/31/2017Q2 2017($0.22)($0.22)($0.22)$0.14 million$0.34 millionN/A
5/15/2017Q1 2017($0.15)($0.22)($0.22)$0.09 million$0.13 millionN/A
8/15/2016Q2 2016($0.23)($0.23)$0.08 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.